Leukemia Stocks List

Recent Signals

Date Stock Signal Type
2019-11-18 ANIX Bollinger Band Squeeze Range Contraction
2019-11-18 CASI 200 DMA Support Bullish
2019-11-18 CASI NR7 Range Contraction
2019-11-18 CASI Narrow Range Bar Range Contraction
2019-11-18 CASI Cup with Handle Other
2019-11-18 DMPI 1,2,3 Pullback Bullish Bullish Swing Setup
2019-11-18 DMPI Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-11-18 EPZM New 52 Week Closing High Bullish
2019-11-18 EPZM Doji - Bearish? Reversal
2019-11-18 EPZM Narrow Range Bar Range Contraction
2019-11-18 EPZM NR7-2 Range Contraction
2019-11-18 EPZM NR7 Range Contraction
2019-11-18 INO Fell Below 20 DMA Bearish
2019-11-18 INO Fell Below 50 DMA Bearish
2019-11-18 INO 180 Bearish Setup Bearish Swing Setup
2019-11-18 SYRS New 52 Week Closing Low Bearish
2019-11-18 SYRS New 52 Week Low Weakness
2019-11-18 SYRS Bollinger Band Squeeze Range Contraction
2019-11-18 TEVA Upper Bollinger Band Walk Strength
2019-11-18 TEVA Pocket Pivot Bullish Swing Setup
2019-11-18 TROV Stochastic Buy Signal Bullish
2019-11-18 TROV 1,2,3 Pullback Bullish Bullish Swing Setup

Leukemia, also spelled leukaemia, is a group of cancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells. These white blood cells are not fully developed and are called blasts or leukemia cells. Symptoms may include bleeding and bruising problems, feeling tired, fever, and an increased risk of infections. These symptoms occur due to a lack of normal blood cells. Diagnosis is typically made by blood tests or bone marrow biopsy.The exact cause of leukemia is unknown. A combination of genetic factors and environmental (non-inherited) factors are believed to play a role. Risk factors include smoking, ionizing radiation, some chemicals (such as benzene), prior chemotherapy, and Down syndrome. People with a family history of leukemia are also at higher risk. There are four main types of leukemia—acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML)—as well as a number of less common types. Leukemias and lymphomas both belong to a broader group of tumors that affect the blood, bone marrow, and lymphoid system, known as tumors of the hematopoietic and lymphoid tissues.Treatment may involve some combination of chemotherapy, radiation therapy, targeted therapy, and bone marrow transplant, in addition to supportive care and palliative care as needed. Certain types of leukemia may be managed with watchful waiting. The success of treatment depends on the type of leukemia and the age of the person. Outcomes have improved in the developed world. The average five-year survival rate is 57% in the United States. In children under 15, the five-year survival rate is greater than 60 to 85%, depending on the type of leukemia. In children with acute leukemia who are cancer-free after five years, the cancer is unlikely to return.In 2015, leukemia was present in 2.3 million people and caused 353,500 deaths. In 2012 it newly developed in 352,000 people. It is the most common type of cancer in children, with three quarters of leukemia cases in children being the acute lymphoblastic type. However, about 90% of all leukemias are diagnosed in adults, with AML and CLL being most common in adults. It occurs more commonly in the developed world.

More about Leukemia